A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects
This study has been completed.
First Posted: October 14, 2010
Last Update Posted: May 22, 2013
Information provided by (Responsible Party):